Page 291 - Read Online

Pasini et al. Hepatoma Res 2020;6:26 I http://dx.doi.org/10.20517/2394-5079.2019.47 Page 7 of 9

2. Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al.; Global Burden of Disease Liver Cancer Collaboration. The burden of
primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level results from the global burden
of disease study 2015. JAMA Oncol 2017;3:1683-91.
3. Kokudo N, Takemura N, Hasegawa K, Takayama T, Kubo S, et al. Clinical practice guidelines for hepatocellular carcinoma: the Japan
Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res 2019;49:1109-13.
4. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol
2018;69:182-236.
5. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update.
Hepatology 2011;53:1020-2.
6. Bralet MP, Régimbeau JM, Pineau P, Dubois S, Loas G, et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and
histopathologic analysis of 80 French cases. Hepatology 2000;32:200-4.
7. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365:1118-27.
8. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus
transplantation. Hepatology 1999;30:1434-40.
9. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, et al. Impact of model for end-stage liver disease (MELD) score on
prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 2006;12:966-71.
10. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg 1995;169:589-94.
11. Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res 2009;39:107-16.
12. Serenari M, Collaud C, Alvarez FA, de Santibañes M, Giunta D, et al. Interstage assessment of remnant liver function in alpps using
hepatobiliary scintigraphy: prediction of posthepatectomy liver failure and introduction of the HIBA index. Ann Surg 2018;267:1141-7.
13. Serenari M, Pettinato C, Bonatti C, Zanoni L, Odaldi F, et al. Hepatobiliary scintigraphy in the preoperative evaluation of potential living
liver donors. Transplant Proc 2019;51:167-70.
14. Cucchetti A, Cescon M, Golfieri R, Piscaglia F, Renzulli M, et al. Hepatic venous pressure gradient in the preoperative assessment of
patients with resectable hepatocellular carcinoma. J Hepatol 2016;64:79-86.
15. Qi X, Zhang X, Li Z, Hui J, Xiang Y, et al. HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma. Oncotarget
2016;7:62789-96.
16. Cescon M, Colecchia A, Cucchetti A, Peri E, Montrone L, et al. Value of transient elastography measured with FibroScan in predicting
the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg 2012;256:706-12.
17. Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, et al. Reply to Letter: “A snapshot of the effective indications and results of
surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational
Study of the HCC East-West Study Group”: when the study setting “ignores” the patients. Ann Surg 2015;262:e30-1.
18. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, et al. Risk factors contributing to early and late phase intrahepatic
recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003;38:200-7.
19. Meniconi RL, Komatsu S, Perdigao F, Boëlle PY, Soubrane O, et al. Recurrent hepatocellular carcinoma: a Western strategy that
emphasizes the impact of pathologic profile of the first resection. Surgery 2015;157:454-62.
20. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate
and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003;237:536-43.
21. Xing H, Zhang WG, Cescon M, Liang L, Li C, et al. Defining and predicting early recurrence after liver resection of hepatocellular
carcinoma: a multi-institutional study. HPB (Oxford) 2019.
22. Joliat GR, Allemann P, Labgaa I, Demartines N, Halkic N. Treatment and outcomes of recurrent hepatocellular carcinomas. Langenbecks
Arch Surg 2017;402:737-44.
23. Erridge S, Pucher PH, Markar SR, Malietzis G, Athanasiou T, et al. Meta-analysis of determinants of survival following treatment of
recurrent hepatocellular carcinoma. Br J Surg 2017;104:1433-42.
24. Wu CC, Cheng SB, Yeh DC, Wang J, P’eng FK. Second and third hepatectomies for recurrent hepatocellular carcinoma are justified. Br J
Surg 2009;96:1049-57.
25. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, et al. Risk factors contributing to early and late phase intrahepatic
recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003;38:200-7.
26. Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and
prognosis. Ann Surg 2015;261:947-55.
27. Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, et al. Second hepatic resection for recurrent hepatocellular carcinoma. Br J Surg
1986;73:434-8.
28. Hu RH, Lee PH, Yu SC, Dai HC, Sheu JC, et al. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk
factors. Surgery 1996;120:23-9.
29. Lee PH, Lin WJ, Tsang YM, Hu RH, Sheu JC, et al. Clinical management of recurrent hepatocellular carcinoma. Ann Surg 1995;222:670-6.
30. Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular
carcinoma. Ann Surg 1998;227:80-5.
31. Sun HC, Tang ZY, Ma ZC, Qin LX, Wang L, et al. The prognostic factor for outcome following second resection for intrahepatic
recurrence of hepatocellular carcinoma with a hepatitis B virus infection background. J Cancer Res Clin Oncol 2005;131:284-8.
32. Huang ZY, Liang BY, Xiong M, Zhan DQ, Wei S, et al. Long-term outcomes of repeat hepatic resection in patients with recurrent
hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Ann Surg Oncol